Reviewing NovelStem International (NSTM) & The Competition

NovelStem International (OTCMKTS:NSTMGet Free Report) is one of 26 public companies in the “Retail stores, not elsewhere classified” industry, but how does it weigh in compared to its peers? We will compare NovelStem International to related businesses based on the strength of its profitability, valuation, institutional ownership, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations and price targets for NovelStem International and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NovelStem International 0 0 0 0 N/A
NovelStem International Competitors 88 811 1393 55 2.60

As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 14.32%. Given NovelStem International’s peers higher possible upside, analysts plainly believe NovelStem International has less favorable growth aspects than its peers.

Valuation & Earnings

This table compares NovelStem International and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
NovelStem International $10,000.00 -$4.19 million -0.25
NovelStem International Competitors $8.16 billion $125.13 million 5.70

NovelStem International’s peers have higher revenue and earnings than NovelStem International. NovelStem International is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares NovelStem International and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NovelStem International -9,166.67% N/A -73.18%
NovelStem International Competitors -25.06% -60.82% -0.94%

Risk & Volatility

NovelStem International has a beta of 0.32, meaning that its stock price is 68% less volatile than the S&P 500. Comparatively, NovelStem International’s peers have a beta of 0.82, meaning that their average stock price is 18% less volatile than the S&P 500.

Institutional and Insider Ownership

29.3% of shares of all “Retail stores, not elsewhere classified” companies are held by institutional investors. 13.6% of NovelStem International shares are held by company insiders. Comparatively, 16.9% of shares of all “Retail stores, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

NovelStem International peers beat NovelStem International on 9 of the 10 factors compared.

NovelStem International Company Profile

(Get Free Report)

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

Receive News & Ratings for NovelStem International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovelStem International and related companies with MarketBeat.com's FREE daily email newsletter.